Skip to main content
. Author manuscript; available in PMC: 2015 Apr 16.
Published in final edited form as: Med Care Res Rev. 2013 Sep 18;71(1):43–60. doi: 10.1177/1077558713503188

Table 1.

Descriptive Statistics for Study Sample of Opioid Treatment Programsa,b.

Variable 2005 2011
Outcome Variables
  Provides buprenorphine for any purpose 98 (49%) 107 (57%)
  Provides buprenorphine for detoxification 76 (37%) 87 (46%)
  Provides buprenorphine for maintenance 73 (36%) 99 (53%)
Sociotechnical
  Percentage of OTP staff who are professionals 35.41 (23.41) 26.57 (18.67)
  Percentage of staff who possess SATS’ credentialing 37.17 (27.23) 37.72 (22.86)
  OTP director has extensive professional networks 8.71 (8.74) 7.49 (4.95)
Organizational-Managerial
  Ownership type
    Publicly owned 40 (20%) 17 (9%)
    Private nonprofit 93 (47%) 109 (59%)
  OTP director rates staff caseload as “high or “too high” 78 (39%) 60 (32%)
  Number of clients served during past year (log) 6.75 (1.11) 6.59 (0.79)
  Percentage of OTP revenue from private insurance 8.27 (17.47) 8.81 (17.23)
Market-Based
  Percentage programs in OTP’s county offer methadone 68.42 (25.36) 53.19 (26.96)
  Population in OTP’s county (log) 13.27 (1.33) 13.34 (1.28)
  Percentage of SATS’ admits for heroin in OTP’s state 19.62 (11.30) 23.08 (8.88)
  Percentage of OTP’s clients in past year injected drugs 38.59 (29.21) 38.49 (27.10)
State Regulation
  State imposes special regulations on OTPs 21 (10%) 71 (38%)
  State funds available to subsidize buprenorphine 42 (20%) 129 (71%)
  State imposes special requirements on prescribing physicians 30 (15%) 8 (5%)
N 202 187

Note. OTP = opioid treatment program; SATS = substance abuse treatment.

a

. Weighted by the total number of clients served in the past year by the OTP.

b

. Counts and percentages (the latter in parentheses) are reported for dichotomous variables and means and standard deviations (the latter in parentheses) are reported for continuous variables.